AMF-responsive doxorubicin loaded β-cyclodextrin-decorated superparamagnetic nanoparticlesElectronic supplementary information (ESI) available. See DOI: 10.1039/c7nj02860a
An alternating magnetic field (AMF)-responsive controlled release system has been developed by the binding of mono-6-deoxy-6-( p -tolylsulfonyl)-β-cyclodextrin (βCD-Ts) onto amine-modified superparamagnetic iron oxide nanoparticles (MNP-NH 2 ), resulting in a MNP-βCD nanocarrier. The structural, che...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 68 |
---|---|
container_issue | 1 |
container_start_page | 671 |
container_title | |
container_volume | 42 |
creator | Santos, Evelyn C. da S Watanabe, Amanda Vargas, Maria D Tanaka, Marcelo N Garcia, Flavio Ronconi, Célia M |
description | An alternating magnetic field (AMF)-responsive controlled release system has been developed by the binding of mono-6-deoxy-6-(
p
-tolylsulfonyl)-β-cyclodextrin (βCD-Ts) onto amine-modified superparamagnetic iron oxide nanoparticles (MNP-NH
2
), resulting in a MNP-βCD nanocarrier. The structural, chemical and colloidal properties of the nanocarrier MNP-βCD were fully evaluated by several techniques. Doxorubicin hydrochloride (DOX), as a model anticancer drug, was loaded onto MNP-βCD resulting in MNP-βCD-DOX and the release process was investigated by varying the temperature (37 and 45 °C), pH (7.4 and 5.0) and presence of an AMF (with and without). DOX can interact with the negatively charged surface of MNP-βCD and also with the cavity of βCD forming inclusion complexes. Under acidic conditions, both the negatively charged surface of MNP-βCD and the ionizable groups of DOX are protonated and the interactions between DOX and the nanocarrier MNP-βCD are weakened, thus, accelerating drug release. Temperature increase can reduce the supramolecular interactions between DOX and the nanocarrier MNP-βCD, favoring DOX release. Thermo-induced burst release at 45 °C has been investigated either by applying an alternating magnetic field (AMF,
f
= 307 kHz) or heating the solution in a thermostatic cuvette holder. In the absence of an AMF at 45 °C and at the pH value of the lysosome (5.0), 92% of DOX was released into the solution within 6 h. Importantly, in an AMF, at 45 (±1) °C and pH = 5.0, the same percentage of DOX release was observed after 50 min. Furthermore,
in vitro
assays revealed that the unloaded MNP-βCD nanoparticles (100 μg mL
−1
) displayed negligible cytotoxicity against A549 human lung adenocarcinoma cells either in the absence or presence of an AMF (
H
×
f
= 4.9 × 10
9
A m
−1
s
−1
) applied for 30 min on the cells. In the presence of an AMF no macroscopic temperature variation was detected in the wells containing the cells incubated with DOX unloaded MNP-βCD nanoparticles. The same amount of DOX loaded nanoparticles (MNP-βCD-DOX) showed cytotoxicity only in the presence of an AMF (
H
×
f
= 4.9 × 10
9
A m
−1
s
−1
applied for 30 min), inducing cell death. Also, no macroscopic temperature variation was detected; therefore, DOX release might be associated with local heating generated from the rotation movements of the nanoparticles (Brown relaxation) upon AMF application. Thus, the DOX loaded β-cyclodextrin-decorated superparamagnetic nanoparticles (MNP-βC |
doi_str_mv | 10.1039/c7nj02860a |
format | Article |
fullrecord | <record><control><sourceid>rsc</sourceid><recordid>TN_cdi_rsc_primary_c7nj02860a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>c7nj02860a</sourcerecordid><originalsourceid>FETCH-rsc_primary_c7nj02860a3</originalsourceid><addsrcrecordid>eNqFj8FKAzEYhIMoWKsX70K86SE16a5b15vULfYgHup9-Zv8KynZJCRpad_Jkw_iM5mD4KFgTzPMNwwMIZeCjwQv6js5sSs-fqg4HJGBKKqa1eNKHGcvypLx-7I6JWcxrjgXYlKJAfl8ep2xgNE7G_UGqXJbF9ZLLbWlxoFCRb-_mNxJ4xRuU9CWKZQuQMokrj0GDwF6-LCYtKQWrMtBtgZjY1Cm4GzOc9Mb7NEmCDuqbedCD0k7S2-axfyWwga0gaXBEV0g0ue3-SPd_3ROTjowES9-dUiuZs379IWFKFsfdJ_H2796MSTX__HWq644tPEDQ8ZtvQ</addsrcrecordid><sourcetype>Enrichment Source</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>AMF-responsive doxorubicin loaded β-cyclodextrin-decorated superparamagnetic nanoparticlesElectronic supplementary information (ESI) available. See DOI: 10.1039/c7nj02860a</title><source>Royal Society Of Chemistry Journals 2008-</source><source>Alma/SFX Local Collection</source><creator>Santos, Evelyn C. da S ; Watanabe, Amanda ; Vargas, Maria D ; Tanaka, Marcelo N ; Garcia, Flavio ; Ronconi, Célia M</creator><creatorcontrib>Santos, Evelyn C. da S ; Watanabe, Amanda ; Vargas, Maria D ; Tanaka, Marcelo N ; Garcia, Flavio ; Ronconi, Célia M</creatorcontrib><description>An alternating magnetic field (AMF)-responsive controlled release system has been developed by the binding of mono-6-deoxy-6-(
p
-tolylsulfonyl)-β-cyclodextrin (βCD-Ts) onto amine-modified superparamagnetic iron oxide nanoparticles (MNP-NH
2
), resulting in a MNP-βCD nanocarrier. The structural, chemical and colloidal properties of the nanocarrier MNP-βCD were fully evaluated by several techniques. Doxorubicin hydrochloride (DOX), as a model anticancer drug, was loaded onto MNP-βCD resulting in MNP-βCD-DOX and the release process was investigated by varying the temperature (37 and 45 °C), pH (7.4 and 5.0) and presence of an AMF (with and without). DOX can interact with the negatively charged surface of MNP-βCD and also with the cavity of βCD forming inclusion complexes. Under acidic conditions, both the negatively charged surface of MNP-βCD and the ionizable groups of DOX are protonated and the interactions between DOX and the nanocarrier MNP-βCD are weakened, thus, accelerating drug release. Temperature increase can reduce the supramolecular interactions between DOX and the nanocarrier MNP-βCD, favoring DOX release. Thermo-induced burst release at 45 °C has been investigated either by applying an alternating magnetic field (AMF,
f
= 307 kHz) or heating the solution in a thermostatic cuvette holder. In the absence of an AMF at 45 °C and at the pH value of the lysosome (5.0), 92% of DOX was released into the solution within 6 h. Importantly, in an AMF, at 45 (±1) °C and pH = 5.0, the same percentage of DOX release was observed after 50 min. Furthermore,
in vitro
assays revealed that the unloaded MNP-βCD nanoparticles (100 μg mL
−1
) displayed negligible cytotoxicity against A549 human lung adenocarcinoma cells either in the absence or presence of an AMF (
H
×
f
= 4.9 × 10
9
A m
−1
s
−1
) applied for 30 min on the cells. In the presence of an AMF no macroscopic temperature variation was detected in the wells containing the cells incubated with DOX unloaded MNP-βCD nanoparticles. The same amount of DOX loaded nanoparticles (MNP-βCD-DOX) showed cytotoxicity only in the presence of an AMF (
H
×
f
= 4.9 × 10
9
A m
−1
s
−1
applied for 30 min), inducing cell death. Also, no macroscopic temperature variation was detected; therefore, DOX release might be associated with local heating generated from the rotation movements of the nanoparticles (Brown relaxation) upon AMF application. Thus, the DOX loaded β-cyclodextrin-decorated superparamagnetic nanoparticles (MNP-βCD-DOX) are a potential controlled drug release agent with cancer-killing properties under an AMF.
An alternating magnetic field (AMF)-responsive controlled release system has been developed by the binding of mono-6-deoxy-6-(p-tolylsulfonyl)-β-cyclodextrin (βCD-Ts) onto amine-modified superparamagnetic iron oxide nanoparticles (MNP-NH
2
), resulting in a MNP-βCD nanocarrier.</description><identifier>ISSN: 1144-0546</identifier><identifier>EISSN: 1369-9261</identifier><identifier>DOI: 10.1039/c7nj02860a</identifier><language>eng</language><creationdate>2017-12</creationdate><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Santos, Evelyn C. da S</creatorcontrib><creatorcontrib>Watanabe, Amanda</creatorcontrib><creatorcontrib>Vargas, Maria D</creatorcontrib><creatorcontrib>Tanaka, Marcelo N</creatorcontrib><creatorcontrib>Garcia, Flavio</creatorcontrib><creatorcontrib>Ronconi, Célia M</creatorcontrib><title>AMF-responsive doxorubicin loaded β-cyclodextrin-decorated superparamagnetic nanoparticlesElectronic supplementary information (ESI) available. See DOI: 10.1039/c7nj02860a</title><description>An alternating magnetic field (AMF)-responsive controlled release system has been developed by the binding of mono-6-deoxy-6-(
p
-tolylsulfonyl)-β-cyclodextrin (βCD-Ts) onto amine-modified superparamagnetic iron oxide nanoparticles (MNP-NH
2
), resulting in a MNP-βCD nanocarrier. The structural, chemical and colloidal properties of the nanocarrier MNP-βCD were fully evaluated by several techniques. Doxorubicin hydrochloride (DOX), as a model anticancer drug, was loaded onto MNP-βCD resulting in MNP-βCD-DOX and the release process was investigated by varying the temperature (37 and 45 °C), pH (7.4 and 5.0) and presence of an AMF (with and without). DOX can interact with the negatively charged surface of MNP-βCD and also with the cavity of βCD forming inclusion complexes. Under acidic conditions, both the negatively charged surface of MNP-βCD and the ionizable groups of DOX are protonated and the interactions between DOX and the nanocarrier MNP-βCD are weakened, thus, accelerating drug release. Temperature increase can reduce the supramolecular interactions between DOX and the nanocarrier MNP-βCD, favoring DOX release. Thermo-induced burst release at 45 °C has been investigated either by applying an alternating magnetic field (AMF,
f
= 307 kHz) or heating the solution in a thermostatic cuvette holder. In the absence of an AMF at 45 °C and at the pH value of the lysosome (5.0), 92% of DOX was released into the solution within 6 h. Importantly, in an AMF, at 45 (±1) °C and pH = 5.0, the same percentage of DOX release was observed after 50 min. Furthermore,
in vitro
assays revealed that the unloaded MNP-βCD nanoparticles (100 μg mL
−1
) displayed negligible cytotoxicity against A549 human lung adenocarcinoma cells either in the absence or presence of an AMF (
H
×
f
= 4.9 × 10
9
A m
−1
s
−1
) applied for 30 min on the cells. In the presence of an AMF no macroscopic temperature variation was detected in the wells containing the cells incubated with DOX unloaded MNP-βCD nanoparticles. The same amount of DOX loaded nanoparticles (MNP-βCD-DOX) showed cytotoxicity only in the presence of an AMF (
H
×
f
= 4.9 × 10
9
A m
−1
s
−1
applied for 30 min), inducing cell death. Also, no macroscopic temperature variation was detected; therefore, DOX release might be associated with local heating generated from the rotation movements of the nanoparticles (Brown relaxation) upon AMF application. Thus, the DOX loaded β-cyclodextrin-decorated superparamagnetic nanoparticles (MNP-βCD-DOX) are a potential controlled drug release agent with cancer-killing properties under an AMF.
An alternating magnetic field (AMF)-responsive controlled release system has been developed by the binding of mono-6-deoxy-6-(p-tolylsulfonyl)-β-cyclodextrin (βCD-Ts) onto amine-modified superparamagnetic iron oxide nanoparticles (MNP-NH
2
), resulting in a MNP-βCD nanocarrier.</description><issn>1144-0546</issn><issn>1369-9261</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqFj8FKAzEYhIMoWKsX70K86SE16a5b15vULfYgHup9-Zv8KynZJCRpad_Jkw_iM5mD4KFgTzPMNwwMIZeCjwQv6js5sSs-fqg4HJGBKKqa1eNKHGcvypLx-7I6JWcxrjgXYlKJAfl8ep2xgNE7G_UGqXJbF9ZLLbWlxoFCRb-_mNxJ4xRuU9CWKZQuQMokrj0GDwF6-LCYtKQWrMtBtgZjY1Cm4GzOc9Mb7NEmCDuqbedCD0k7S2-axfyWwga0gaXBEV0g0ue3-SPd_3ROTjowES9-dUiuZs379IWFKFsfdJ_H2796MSTX__HWq644tPEDQ8ZtvQ</recordid><startdate>20171218</startdate><enddate>20171218</enddate><creator>Santos, Evelyn C. da S</creator><creator>Watanabe, Amanda</creator><creator>Vargas, Maria D</creator><creator>Tanaka, Marcelo N</creator><creator>Garcia, Flavio</creator><creator>Ronconi, Célia M</creator><scope/></search><sort><creationdate>20171218</creationdate><title>AMF-responsive doxorubicin loaded β-cyclodextrin-decorated superparamagnetic nanoparticlesElectronic supplementary information (ESI) available. See DOI: 10.1039/c7nj02860a</title><author>Santos, Evelyn C. da S ; Watanabe, Amanda ; Vargas, Maria D ; Tanaka, Marcelo N ; Garcia, Flavio ; Ronconi, Célia M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-rsc_primary_c7nj02860a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Santos, Evelyn C. da S</creatorcontrib><creatorcontrib>Watanabe, Amanda</creatorcontrib><creatorcontrib>Vargas, Maria D</creatorcontrib><creatorcontrib>Tanaka, Marcelo N</creatorcontrib><creatorcontrib>Garcia, Flavio</creatorcontrib><creatorcontrib>Ronconi, Célia M</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Santos, Evelyn C. da S</au><au>Watanabe, Amanda</au><au>Vargas, Maria D</au><au>Tanaka, Marcelo N</au><au>Garcia, Flavio</au><au>Ronconi, Célia M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AMF-responsive doxorubicin loaded β-cyclodextrin-decorated superparamagnetic nanoparticlesElectronic supplementary information (ESI) available. See DOI: 10.1039/c7nj02860a</atitle><date>2017-12-18</date><risdate>2017</risdate><volume>42</volume><issue>1</issue><spage>671</spage><epage>68</epage><pages>671-68</pages><issn>1144-0546</issn><eissn>1369-9261</eissn><abstract>An alternating magnetic field (AMF)-responsive controlled release system has been developed by the binding of mono-6-deoxy-6-(
p
-tolylsulfonyl)-β-cyclodextrin (βCD-Ts) onto amine-modified superparamagnetic iron oxide nanoparticles (MNP-NH
2
), resulting in a MNP-βCD nanocarrier. The structural, chemical and colloidal properties of the nanocarrier MNP-βCD were fully evaluated by several techniques. Doxorubicin hydrochloride (DOX), as a model anticancer drug, was loaded onto MNP-βCD resulting in MNP-βCD-DOX and the release process was investigated by varying the temperature (37 and 45 °C), pH (7.4 and 5.0) and presence of an AMF (with and without). DOX can interact with the negatively charged surface of MNP-βCD and also with the cavity of βCD forming inclusion complexes. Under acidic conditions, both the negatively charged surface of MNP-βCD and the ionizable groups of DOX are protonated and the interactions between DOX and the nanocarrier MNP-βCD are weakened, thus, accelerating drug release. Temperature increase can reduce the supramolecular interactions between DOX and the nanocarrier MNP-βCD, favoring DOX release. Thermo-induced burst release at 45 °C has been investigated either by applying an alternating magnetic field (AMF,
f
= 307 kHz) or heating the solution in a thermostatic cuvette holder. In the absence of an AMF at 45 °C and at the pH value of the lysosome (5.0), 92% of DOX was released into the solution within 6 h. Importantly, in an AMF, at 45 (±1) °C and pH = 5.0, the same percentage of DOX release was observed after 50 min. Furthermore,
in vitro
assays revealed that the unloaded MNP-βCD nanoparticles (100 μg mL
−1
) displayed negligible cytotoxicity against A549 human lung adenocarcinoma cells either in the absence or presence of an AMF (
H
×
f
= 4.9 × 10
9
A m
−1
s
−1
) applied for 30 min on the cells. In the presence of an AMF no macroscopic temperature variation was detected in the wells containing the cells incubated with DOX unloaded MNP-βCD nanoparticles. The same amount of DOX loaded nanoparticles (MNP-βCD-DOX) showed cytotoxicity only in the presence of an AMF (
H
×
f
= 4.9 × 10
9
A m
−1
s
−1
applied for 30 min), inducing cell death. Also, no macroscopic temperature variation was detected; therefore, DOX release might be associated with local heating generated from the rotation movements of the nanoparticles (Brown relaxation) upon AMF application. Thus, the DOX loaded β-cyclodextrin-decorated superparamagnetic nanoparticles (MNP-βCD-DOX) are a potential controlled drug release agent with cancer-killing properties under an AMF.
An alternating magnetic field (AMF)-responsive controlled release system has been developed by the binding of mono-6-deoxy-6-(p-tolylsulfonyl)-β-cyclodextrin (βCD-Ts) onto amine-modified superparamagnetic iron oxide nanoparticles (MNP-NH
2
), resulting in a MNP-βCD nanocarrier.</abstract><doi>10.1039/c7nj02860a</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1144-0546 |
ispartof | |
issn | 1144-0546 1369-9261 |
language | eng |
recordid | cdi_rsc_primary_c7nj02860a |
source | Royal Society Of Chemistry Journals 2008-; Alma/SFX Local Collection |
title | AMF-responsive doxorubicin loaded β-cyclodextrin-decorated superparamagnetic nanoparticlesElectronic supplementary information (ESI) available. See DOI: 10.1039/c7nj02860a |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A56%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-rsc&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AMF-responsive%20doxorubicin%20loaded%20%CE%B2-cyclodextrin-decorated%20superparamagnetic%20nanoparticlesElectronic%20supplementary%20information%20(ESI)%20available.%20See%20DOI:%2010.1039/c7nj02860a&rft.au=Santos,%20Evelyn%20C.%20da%20S&rft.date=2017-12-18&rft.volume=42&rft.issue=1&rft.spage=671&rft.epage=68&rft.pages=671-68&rft.issn=1144-0546&rft.eissn=1369-9261&rft_id=info:doi/10.1039/c7nj02860a&rft_dat=%3Crsc%3Ec7nj02860a%3C/rsc%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |